Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Brief Genetics Reports

Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate

  1. Christopher J. Groves12,
  2. Eleftheria Zeggini2,
  3. Mark Walker3,
  4. Graham A. Hitman4,
  5. Jonathan C. Levy1,
  6. Stephen O’Rahilly5,
  7. Andrew T. Hattersley6,
  8. Mark I. McCarthy12 and
  9. Steven Wiltshire2
  1. 1Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K
  2. 2Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K
  3. 3School of Clinical Medical Sciences, University of Newcastle, Newcastle, U.K
  4. 4Department of Diabetes and Metabolic Medicine, Bart’s and The London Queen Mary’s School of Medicine and Dentistry, London, U.K
  5. 5Departments of Medicine and Clinical Biochemistry, Addenbrooke’s Hospital, Cambridge, U.K
  6. 6Centre for Molecular Genetics, Peninsula Medical School, Exeter, U.K
  1. Address correspondence and reprint requests to Prof. Mark McCarthy, Robert Turner Professor of Diabetes, Oxford Centre for Diabetes, EndocrinologyMetabolism, Churchill Hospital, Old Road, Oxford, OX3 7LJ, U.K. E-mail: mark.mccarthy{at}drl.ox.ac.uk
Diabetes 2006 Jun; 55(6): 1884-1889. https://doi.org/10.2337/db05-1674
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    A: A genome-wide quantitative trait multipoint linkage analysis of BMI in 573 pedigrees. The vertical broken lines indicate chromosome boundaries. The analysis was carried out using MERLIN-REGRESS, as described in the text. B: Chromosome 10 quantitative trait multipoint linkage analysis of BMI. The microsatellite markers used in the analysis are shown along the top. The position of the centromere is indicated on the x-axis. The linkage results from nine previous studies of BMI and obesity are shown below the x-axis by diamonds. The sizes of diamonds are proportional to −log(P value) of the maximum LOD (or nonparametric linkage) scores reported in the respective articles, the positions of which represent the locations of the linkage peaks, converted where appropriate into Haldane centimorgan units [cM(H)], from the respective reports. Locus boundaries (indicated by horizontal lines) were either undefined (15), author defined (7,11,14), or estimated as a 1-LOD support interval (8–10,12,13).

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Genomic structure and LD relationships of the GAD2 gene. A: Top to bottom: Base pair position (National Center for Biotechnology Information build 35), genomic structure of GAD2, sequence coverage of the gene by Environmental Genome Project (EGP), SNPs discovered by EGP, and haplotype block structure based on EGP SNP data. The eight SNPs in the present study are shown in full and condensed. B: Genomic positions, minor allele frequencies, and pairwise LD relationships (r2 measures above the diagonal and D′ measures below) for the eight SNPs typed in the present study.

Tables

  • Figures
  • TABLE 1

    Tests of total association of individual GAD2 SNPs with BMI

    GAD2 SNP(s)Total association (P value)
    Trait means (Z scores)*
    QTDTQPDTPHASECommon alleleMinor allele
    Initial three SNPs
        rs22364180.0250.0510.280.13
        rs9929900.0920.0550.290.19
        rs9281970.0110.0170.290.12
    Subsequent five SNPs
        rs28396690.0360.0380.290.15
        rs70719220.0310.0290.300.17
        rs3781117>0.10.9960.270.25
        rs7908975>0.10.5550.270.25
        rs3781107>0.10.4320.280.22
    • *

      * Mean trait values from QPDTPHASE. The trait values are Z scores (i.e., log-transformed BMI adjusted for the effects of age and sex and standardized against the U.K. population [3]).

  • TABLE 2

    Tests of association of block-tagging GAD2 SNP combinations with BMI

    Block tagging GAD2 SNP combinationGlobal QPDTPHASE (P value)*Significant haplotypes {frequency} (trait mean) [P value]†
    rs2839669, rs22364180.04911 {0.901} (0.29) [0.051]22 {0.097} (0.14) [0.038]
    rs7071922, rs3781117, rs79089750.044111 {0.639} (0.31) [0.048]211 {0.166} (0.14) [0.010]
    rs992990, rs928197, rs37811070.032111 {0.629} (0.31) [0.025]221 {0.119} (0.13) [0.014]
    • *

      * Haplotypes of these SNPs are examined in a global (or omnibus) test, with rare (<1% frequency) haplotypes pooled.

    • †

      † Significant haplotypes from the haplotype-specific comparisons from QPDTPHASE. 1, common allele; 2, rare allele. For all three GAD2 SNP combinations, only two haplotypes were significant in the haplotype-specific comparisons. The frequency and mean trait values (Z scores) for each haplotype are shown. P values (all uncorrected for multiple testing) are for the haplotype in question tested against all others pooled.

  • TABLE 3

    Tests of multipoint linkage and association of GAD2 with BMI

    Associated GAD2 SNP(s)Analyses assuming one SNP cluster
    Analyses assuming three SNP clusters
    Linkage alone (LOD)Linkage given association (LOD)Linkage alone (LOD)Linkage given association (LOD)
    rs28396693.883.544.323.94
    rs22364184.083.584.624.09
    rs2839669, rs22364184.193.794.774.31
    rs70719222.882.793.253.12
    rs7071922, rs3781117, rs79089752.802.553.183.00
    rs9281973.633.144.193.63
    rs992990, rs928197, rs37811073.282.883.843.47
    • Linkage alone: baseline multipoint LOD score for linkage to BMI calculated only in those individuals who have genotypes for the GAD2 SNP in question. Linkage given association: multipoint LOD score for linkage to BMI after the GAD2 association has been accounted for, by adjustment on the GAD2 covariate.

PreviousNext
Back to top

In this Issue

June 2006, 55(6)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate
Christopher J. Groves, Eleftheria Zeggini, Mark Walker, Graham A. Hitman, Jonathan C. Levy, Stephen O’Rahilly, Andrew T. Hattersley, Mark I. McCarthy, Steven Wiltshire
Diabetes Jun 2006, 55 (6) 1884-1889; DOI: 10.2337/db05-1674

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate
Christopher J. Groves, Eleftheria Zeggini, Mark Walker, Graham A. Hitman, Jonathan C. Levy, Stephen O’Rahilly, Andrew T. Hattersley, Mark I. McCarthy, Steven Wiltshire
Diabetes Jun 2006, 55 (6) 1884-1889; DOI: 10.2337/db05-1674
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Krüppel-Like Factor 11 (KLF11) Q62R Polymorphism Is Not Associated With Type 2 Diabetes in 8,676 People
  • CHRM3 Gene Variation Is Associated With Decreased Acute Insulin Secretion and Increased Risk for Early-Onset Type 2 Diabetes in Pima Indians
  • Polymorphism in the Transcription Factor 7-Like 2 (TCF7L2) Gene Is Associated With Reduced Insulin Secretion in Nondiabetic Women
Show more Brief Genetics Reports

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.